2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1669094223 MD
Verify on CMS →

SARA GABERE, MD

Addiction Medicine (Psychiatry & Neurology) Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
342
Medicare Part D claims · 27 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

SARA GABERE, MD filed 342 Medicare Part D claims in 2023 as a Addiction Medicine (Psychiatry & Neurology) Physician in NEW YORK, New York, prescribing 89% generic.

342
Part D claims, 2023
89%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SARA GABERE, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

342 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

SARA GABERE, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SARA GABERE, MD?

Quality data not reported

NPI registry status

Active

Issued 05/17/2020

NPI 1669094223

Primary specialty

Addiction Medicine (Psychiatry & Neurology) Physician

Niche

658 US NPIs in this specialty

Medicare Part D claims

342 66% vs specialty avg

2023 prescription claims

Specialty avg: 1,019

Specialty distribution in New York

How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among New York providers

New York providers

Addiction Medicine (Psychiatry & Neurology) Physician share within New York

1. Addiction Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Psychiatry & Neurology) Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Medicine (Psychiatry & Neurology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Medicine (Psychiatry & Neurology) Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SARA GABERE, MD appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider holding MD credentials at 550 1ST AVE, NEW YORK, NY, 10016, with a listed phone of (212) 263-7300. NPI 1669094223 was issued on 05/17/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GABERE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 342 prescription claims written by this provider, covering 27 Medicare beneficiaries and totaling roughly $31K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

550 1ST AVE
NEW YORK, NY 10016

Provider Details

NPI 1669094223
Specialty Addiction Medicine (Psychiatry & Neurology) Physician
Credentials MD
Gender Female
NPI Issued 05/17/2020

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to SARA GABERE, MD. To verify SARA GABERE, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

SARA GABERE, MD — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 342 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

342
Total Claims
$31K
Total Drug Cost
27
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
387
Total Day Supply
11,455
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$24K
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
59.2 years
Avg HCC Risk Score
1.55
Gender Split
59% female / 41% male
Age Distribution
<65: 14, 65-74: N/A, 75-84: N/A, 85+: 0

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SARA GABERE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Quetiapine Fumarate
33
Trazodone Hcl
27
Fluoxetine Hcl
23
Bupropion Xl
Bupropion Hcl
21
Gabapentin
20
Trintellix
Vortioxetine Hydrobromide
19
Naltrexone Hcl
18
Clonazepam
16
Risperidone
15
Aripiprazole
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Psychiatry & Neurology) Physician Overview

How SARA GABERE, MD fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.

658
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,019
Avg Claims per Provider

SARA GABERE, MD's 342 claims are below the specialty average of 1,019.

Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GABERE.

Compare Addiction Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SARA GABERE, MD's specialty?
SARA GABERE, MD specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in NEW YORK, New York. Credentials: MD.
How much does SARA GABERE, MD prescribe under Medicare Part D?
In 2023, SARA GABERE, MD wrote 342 Medicare Part D claims totaling $31K in drug costs for 27 beneficiaries.
Where is SARA GABERE, MD located?
SARA GABERE, MD is located at 550 1ST AVE, NEW YORK, NY, 10016. Phone: (212) 263-7300.
What is SARA GABERE, MD's NPI number?
SARA GABERE, MD's National Provider Identifier (NPI) is 1669094223, issued on 05/17/2020.
Does SARA GABERE, MD prescribe more brand-name or generic drugs?
SARA GABERE, MD's prescribing is 11% brand-name and 89% generic drugs by claim count, with $24K in brand drug costs.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 658 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,019 Medicare Part D claims per year.
What drugs does SARA GABERE, MD prescribe most often?
Based on 2023 Medicare Part D data, SARA GABERE, MD's most frequently prescribed drugs include Quetiapine Fumarate, Trazodone Hcl, Fluoxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SARA GABERE, MD accept Medicare?
SARA GABERE, MD appears in CMS Medicare data with 342 Part D claims and 27 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SARA GABERE, MD's credentials?
SARA GABERE, MD's NPI is 1669094223 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology